Company Analysis

Definium Therapeutics, Inc. (DFTX)

Nasdaq: DFTX · Medicinal Chemicals & Botanical Products · New York, NY · filing with the SEC since 2020
Grade5.3
◀ Past 4.4● Present 5.2▶ Future 6.5
6 est.

The company now

Definium Therapeutics, Inc. is classed by the SEC under Medicinal Chemicals & Botanical Products (industry code 2833), based in New York, NY. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported a loss of $184 million (its filed statements).

From its filings and filed figures; the desk's account of it is not written yet.

The desk's written account, its read of the annual report, the record in brief and the split of the revenue are not on file for this company yet.

SI Assistanton DFTX · research, not advice